Literature DB >> 18572165

Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.

P G Franco1, L Silvestroff, E F Soto, J M Pasquini.   

Abstract

In the present work we analyzed the capacity of thyroid hormones (THs) to improve remyelination using a rat model of cuprizone-induced demyelination previously described in our laboratories. Twenty one days old Wistar rats were fed a diet containing 0.6% cuprizone for two weeks to induce demyelination. After cuprizone withdrawal, rats were injected with triiodothyronine (T3). Histological studies carried out in these animals revealed that remyelination in the corpus callosum (CC) of T3-treated rats improved markedly when compared to saline treated animals. The cellular events occurring in the CC and in the subventricular zone (SVZ) during the first week of remyelination were analyzed using specific oligodendroglial cell (OLGc) markers. In the CC of saline treated demyelinated animals, mature OLGcs decreased and oligodendroglial precursor cells (OPCs) increased after one week of spontaneous remyelination. Furthermore, the SVZ of these animals showed an increase in early progenitor cell numbers, dispersion of OPCs and inhibition of Olig and Shh expression compared to non-demyelinated animals. The changes triggered by demyelination were reverted after T3 administration, suggesting that THs could be regulating the emergence of remyelinating oligodendrocytes from the pool of proliferating cells residing in the SVZ. Our results also suggest that THs receptor beta mediates T3 effects on remyelination. These results support a potential role for THs in the remyelination process that could be used to develop new therapeutic approaches for demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572165     DOI: 10.1016/j.expneurol.2008.04.039

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  46 in total

1.  Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage.

Authors:  Linnea R Vose; Govindaiah Vinukonda; Sungro Jo; Omid Miry; Daniel Diamond; Ritesh Korumilli; Arslan Arshad; Muhammad T K Zia; Furong Hu; Robert J Kayton; Edmund F La Gamma; Rashmi Bansal; Antonio C Bianco; Praveen Ballabh
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

2.  Rapid Serum-Free Isolation of Oligodendrocyte Progenitor Cells from Adult Rat Spinal Cord.

Authors:  John Bianco; Dario Carradori; Ronald Deumens; Anne des Rieux
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

3.  The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.

Authors:  Jason C Dugas; Adiljan Ibrahim; Ben A Barres
Journal:  Mol Cell Neurosci       Date:  2012-03-24       Impact factor: 4.314

Review 4.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

Review 5.  Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal.

Authors:  Jae Young Lee; Steven Petratos
Journal:  Mol Neurobiol       Date:  2016-07-18       Impact factor: 5.590

6.  Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.

Authors:  Emily G Baxi; Joseph DeBruin; Jing Jin; Hayley J Strasburger; Matthew D Smith; Jennifer L Orthmann-Murphy; Jason T Schott; Amanda N Fairchild; Dwight E Bergles; Peter A Calabresi
Journal:  Glia       Date:  2017-09-22       Impact factor: 7.452

7.  A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.

Authors:  Emily G Baxi; Jason T Schott; Amanda N Fairchild; Leslie A Kirby; Rabia Karani; Prech Uapinyoying; Carlos Pardo-Villamizar; Jeffrey R Rothstein; Dwight E Bergles; Peter A Calabresi
Journal:  Glia       Date:  2014-05-24       Impact factor: 7.452

8.  Sobetirome prodrug esters with enhanced blood-brain barrier permeability.

Authors:  Andrew T Placzek; Skylar J Ferrara; Meredith D Hartley; Hannah S Sanford-Crane; J Matthew Meinig; Thomas S Scanlan
Journal:  Bioorg Med Chem       Date:  2016-09-16       Impact factor: 3.641

9.  Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.

Authors:  Adib Zendedel; Iraj Ragerdi Kashani; Maryam Azimzadeh; Parichehr Pasbakhsh; Negar Omidi; Abolfazl Golestani; Cordian Beyer; Tim Clarner
Journal:  Metab Brain Dis       Date:  2016-01-04       Impact factor: 3.584

10.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.